文献速递心脏核医学肿瘤 PET/CT

PET在动脉粥样硬化和易损斑块中的临床作用?

A Clinical Role of PET in Atherosclerosis and Vulnerable Plaques?
PubMed 文献 · Semin Nucl Med · 2020-03-20

动脉粥样硬化是慢性进展性疾病,斑块破裂或侵蚀可导致急性动脉血栓事件。斑块从无症状到症状性进展取决于其结构和组成,炎症起关键作用。本综述强调PET成像在探索动脉粥样硬化斑块代谢活动中的作用,总结FDG-PET临床研究证据并讨论易损斑块成像新型放射性药物的前景。

要点

  • 动脉粥样硬化进展速度在患者间及同一患者内高度可变,斑块破裂或侵蚀可随时导致急性动脉血栓事件。
  • 破裂斑块原型含大而软的富脂质坏死核心伴斑块内出血,占斑块体积一半以上,表面覆盖薄且有炎症的纤维帽。
  • FDG-PET成像已成为无创探索动脉粥样硬化斑块炎症活动的有力工具,提供血管壁代谢活动随时间演变的新见解。

核心结论

  • 本综述强调PET成像在探索动脉粥样硬化斑块代谢活动中的作用,并讨论易损斑块成像新型放射性药物的前景。

研究设计与样本

  • 本综述汇总临床研究中使用FDG-PET获得的证据,并讨论易损斑块成像新型放射性药物的前景。

主要发现

  • 动脉粥样硬化是慢性且最常为进展性的疾病,临床沉默期长,斑块破裂或侵蚀可随时导致急性动脉血栓事件。
  • 斑块从无症状进展为症状性取决于其结构和组成,其中炎症起关键作用。
  • 破裂斑块原型含大而软的富脂质坏死核心伴斑块内出血,占斑块体积一半以上,覆盖薄且有炎症的纤维帽含少量平滑肌细胞和大量炎症细胞浸润。
  • CT血管造影和MRI可表征斑块形态,而分子成像因核医学对组织中放射性药物检测的高灵敏度,可探索斑块生物学。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Atherosclerosis is a chronic and most often progressive disease with a long clinically apparently silent period, and can become unstable at any time, due to a plaque rupture or erosion, leading to an acute atherothrombotic event. Atherosclerosis has a progression rate that is highly variable among patients and in the same patient. The progression of atherosclerotic plaque from asymptomatic to symptomatic phase depends on its structure and composition in which inflammation plays an essential role. Prototype of the ruptured plaque contains a large, soft, lipid-rich necrotic core with intraplaque hemorrhage that accounts for more than half of the volume of the plaque covered by a thin and inflamed fibrous cap with few smooth muscle cells, and a heavy infiltrate of inflammatory cells. Noninvasive imaging modalities might provide an assessment of the atherosclerotic disease process through the exploration of these plaque features. Computed tomography angiography and magnetic resonance imaging can characterize plaque morphology, whereas molecular imaging, owing to the high sensitivity of nuclear medicine for the detection of radiopharmaceuticals in tissues, allows to explore plaque biology. During the last 2 decades, FDG-PET imaging has also emerged as a powerful tool to explore noninvasively inflammatory activities in atherosclerotic plaques providing new insights on the evolution of metabolic activities in the vascular wall over time. This review highlights the role of PET imaging for the exploration of metabolic activities in atherosclerotic plaques. It will resume the evidence that have been gathered from clinical studies using FDG-PET and will discuss the perspectives of new radiopharmaceuticals for vulnerable plaque imaging.

来源:Semin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Lairez O, Hyafil F. A Clinical Role of PET in Atherosclerosis and Vulnerable Plaques? Semin Nucl Med. 2020. PMID: 32540028. doi:10.1053/j.semnuclmed.2020.02.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。